By Dr. Shezad Malik, M.D., J.D. — Board-Certified Physician & Product Liability Trial Attorney The Issue: Lawsuits allege Dupixent blocks immune pathways, which may cause or accelerate rare skin cancers (Cutaneous T-Cell Lymphoma). The Lawsuit: Claims assert that manufacturers failed to warn doctors to run skin biopsies before prescribing the medication. Who Qualifies: Anyone who … Continue reading Dupixent Lymphoma Lawsuit: Claims, Risks & Financial Compensation Options